Skip to main content
Caplight Logo









Emerald Health Pharmaceuticals

Emerald Health Pharmaceuticals

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://emeraldpharma.life/

Last Round

Private Placement

Mar 28, 2021

Est. Valuation

$132.4M

Total Funding Raised

$328,500

Company Overview

Emerald Health Pharmaceuticals is a biotechnology company that develops novel therapeutic molecules derived from synthetic cannabinoids to treat neurodegenerative, autoimmune, inflammatory, and fibrotic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverysynthetic cannabinoidsclinical trialsnew chemical entitiesNCEneurodegenerative diseaseautoimmune diseasecannabinoid therapeuticspharma R&Drational drug designfibrotic diseasebiotech startupcannabis pharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Emerald Health Pharmaceuticals Comparables

Compare Emerald Health Pharmaceuticals with similar companies based on industry and business-model similarity.

Emerald Health Pharmaceuticals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Synendos Therapeutics
75%
Minoryx Therapeutics
74%
InMed Pharmaceuticals
71%

Emerald Health Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private PlacementMar 28, 2021
SeedJun 30, 2019
Private PlacementJun 27, 2019

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 8, 2025

    Grew 25% QoQ from 12 to 15 employees.

  • Mar 28, 2021

    $43M raised in a private placement round.

Emerald Health Pharmaceuticals Filings

Explore SEC and related filing metadata, where available.

Emerald Health Pharmaceuticals filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Emerald Health Pharmaceuticals's valuation, stock price, and market status.

Is Emerald Health Pharmaceuticals a public or private company?

Emerald Health Pharmaceuticals is a private company.

What is the current stock price of Emerald Health Pharmaceuticals?

Emerald Health Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.

How much is Emerald Health Pharmaceuticals worth (valuation)?

Emerald Health Pharmaceuticals's valuation is estimated at $132.4M based on funding round data.

Can I buy Emerald Health Pharmaceuticals stock?

Emerald Health Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Emerald Health Pharmaceuticals's last funding round?

Emerald Health Pharmaceuticals's most recent funding round was Private Placement on March 28, 2021.

Who are the main investors in Emerald Health Pharmaceuticals?

Investor information for Emerald Health Pharmaceuticals is not publicly disclosed.

Will Emerald Health Pharmaceuticals IPO soon?

No public IPO plans have been announced for Emerald Health Pharmaceuticals.

How can I track Emerald Health Pharmaceuticals secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Emerald Health Pharmaceuticals's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range2
Year Founded2017
Last FundingMar 28, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?